Human umbilical cord matrix stem cells: Preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease

Stem Cells

Volumn 24, Issue 3, 2006, Pages 781-792

  Weiss, Mark L ^a   Medicetty, Satish ^a   Bledsoe, Amber R ^a   Rachakatla, Raja Shekar ^a   Choi, Michael ^b   Merchav, Shosh ^b   Luo, Yongquan ^c   Rao, Mahendra S ^c   Velagaleti, Gopalrao ^d   Troyer, Deryl ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b ViaCell Singapore Research Centre   (Singapore)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d Dept Pediatrics   (United States)

Author keywords

Flow cytometry; In vitro expansion Noncontroversial source of stem cells; Regenerative medicine; Wharton's jelly

Indexed keywords

ALPHA5 INTEGRIN; BETA1 INTEGRIN; CD14 ANTIGEN; CD31 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; ENDOGLIN; HERMES ANTIGEN; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; PROTEIN SH2; THY 1 ANTIGEN; DIFFERENTIATION ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; BRAIN; BRAIN TUMOR; CELL DIFFERENTIATION; CELL POPULATION; CIRCLING BEHAVIOR; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; RAT; STEM CELL; STEM CELL TRANSPLANTATION; UMBILICAL CORD; UMBILICAL CORD MATRIX STEM CELL; ANIMAL; ANIMAL BEHAVIOR; CYTOLOGY; IMMUNOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; PARKINSONISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

RODENTIA;

ANIMALS; ANTIGENS, DIFFERENTIATION; BEHAVIOR, ANIMAL; BRAIN NEOPLASMS; FEMALE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; UMBILICAL CORD;

EID: 33744973827     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0330     Document Type: Article

References (63)

1. Kuehnle I, Goodell MA. The therapeutic potential of stem cells from adults. BMJ 2002;325:372-376.
2. Daar AS, Sheremeta L. The science of stem cells: Ethical, legal and social issues. Exp Clin Transplant 2003;1:139-146.
3. de Wert G, Mummery C. Human embryonic stem cells: Research, ethics and policy. Hum Reprod 2003;18:672-682.
4. Denker H. Embryonic stem cells: An exciting field for basic research and tissue engineering, but also an ethical dilemma? Cells Tissues Organs 1999;165:246-249.
5. Henon PR. Human embryonic or adult stem cells: An overview on ethics and perspectives for tissue engineering. Adv Exp Med Biol 2003;534:27-45.
6. Paul G, Li JY, Brundin P. Stem cells: Hype or hope? Drug Discov Today 2002;7:295-302.
7. Romano G. Stem cell transplantation therapy: Controversy over ethical issues and clinical relevance. Drug News Perspect 2004;17:637-645.
8. Kogler G, Sensken S, Airey JA et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004;200:123-135.
9. Jiang Y, Vaessen B, Lenvik T et al. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 2002;30:896-904.
10. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49.
11. Young HE, Duplaa C, Yost MJ et al. Clonogenic analysis reveals reserve stem cells in postnatal mammals. II. Pluripotent epiblastic-like stem cells. Anat Rec A Discov Mol Cell Evol Biol 2004;277:178-203.
12. Hao QL, Shah AJ, Thiemann FT et al. A functional comparison of CD34+ CD38- cells in cord blood and bone marrow. Blood 1995;86:3745-3753.
13. Schwinger W, Urban C, Lackner H et al. Unrelated 5/6-locus matched umbilical cord blood transplantation in a 23-month-old child with hemophagocytic lymphohistiocytosis. Bone Marrow Transplant 1998;22:393-396.
14. Kogler G, Callejas J, Hakenberg P et al. Hematopoietic transplant potential of unrelated cord blood: Critical issues. J Hematother 1996;5:105-116.
15. Broxmeyer HE, Gluckman E, Auerbach A et al. Human umbilical cord blood: A clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J Cell Cloning 1990;8(suppl 1):76-89.
16. Kelly P, Kurtzberg J, Vichinsky E et al. Umbilical cord blood stem cells: Application for the treatment of patients with hemoglobinopathies. J Pediatr 1997;130:695-703.
17. Cohen Y, Nagler A. Cord blood biology and transplantation. Isr Med Assoc J 2004;6:39-46.
18. Warwick R, Armitage S. Cord blood banking. Best Pract Res Clin Obstet Gynaecol 2004;18:995-1011.
19. Kogler G, Radke TF, Lefort A et al. Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp Hematol 2005;33:573-583.
20. Carlson BM. Human Embryology and Developmental Biology, Third Edition. 2004.
21. Fu YS, Shih YT, Cheng YC et al. Transformation of human umbilical mesenchymal cells into neurons in vitro. J Biomed Sci 2004;11:652-660.
22. Sarugaser R, Lickorish D, Baksh D et al. Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. STEM CELLS 2005;23:220-229.
23. Wang HS, Hung SC, Peng ST et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. STEM CELLS 2004;22:1330-1337.
24. Mitchell KE, Weiss ML, Mitchell BM et al. Wharton's Jelly mesenchymal cells form neurons and glia. STEM CELLS 2003;21:50-60.
25. Lee OK, Kuo TK, Chen WM et al. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004;103:1669-1675.
26. Arenas E. Stem cells in the treatment of Parkinson's disease. Brain Res Bull 2002;57:795-808.
27. Bjorklund LM, Sanchez-Pernaute R, Chung S et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A 2002;99:2344-2349.
28. Kim JH, Auerbach JM, Rodriguez-Gomez JA et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002;418:50-56.
29. Nishimura F, Yoshikawa M, Kanda S et al. Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: Improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. STEM CELLS 2003;21:171-180.
30. Storch A, Schwarz J. Neural stem cells and Parkinson's disease. J Neurol 2002;249(suppl 3):III/30-III/32.
31. Medicetty S, Bledsoe A, Fahrenholtz CB et al. Transplantation of pig stem cells into rat brain: Proliferation during the first 8 weeks. Exp Neurol 2004;190:32-40.
32. Weiss ML, Mitchell KE, Hix JE et al. Transplantation of porcine umbilical cord matrix cells into the rat brain. Exp Neurol 2003;182:288-299.
33. Velagaleti GV, Tapper JK, Panova NE et al. Cytogenetic findings in a case of nodular fasciitis of subclavicular region. Cancer Genet Cytogenet 2003;141:160-163.
34. Velagaleti GV, Tapper JK, Rampy BA et al. A rapid and noninvasive method for detecting tissue-limited mosaicism: Detection of i(12)(p10) in buccal smear from a child with Pallister-Killian syndrome. Genet Test 2003;7:219-223.
35. Ungerstedt U, Arbuthnott GW. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 1970;24:485-493.
36. Watson RE Jr, Wiegand SJ, Clough RW et al. Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides 1986;7:155-159 [published erratum appears in Peptides 1986;7:545].
37. Laughlin MJ, Eapen M, Rubinstein P et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004;351:2265-2275.
38. Kadereit S, Junge GR, Kleen T et al. Deficient IFN-gamma expression in umbilical cord blood (UCB) T cells can be rescued by IFN-gamma-mediated increase in NFATc2 expression. J Clin Immunol 2003;23:485-497.
39. Woodbury D, Schwarz EJ, Prockop DJ et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000;61:364-370.
40. Ivanova NB, Dimos JT, Schaniel C et al. A stem cell molecular signature. Science 2002;298:601-604.
41. Ramalho-Santos M, Yoon S, Matsuzaki Y et al. "Stemness": Transcriptional profiling of embryonic and adult stem cells. Science 2002;298:597-600.
42. Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: Candidate MSC-like cells from umbilical cord. STEM CELLS 2003;21:105-110.
43. Covas DT, Siufi JL, Silva AR et al. Isolation and culture of umbilical vein mesenchymal stem cells. Braz J Med Biol Res 2003;36:1179-1183.
44. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000;109:235-242.
45. Prusa AR, Marton E, Rosner M et al. Oct-4-expressing cells in human amniotic fluid: A new source for stem cell research? Hum Reprod 2003;18:1489-1493.
46. Tsai MS, Lee JL, Chang YJ et al. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004;19:1450-1456.
47. Zhang Y, Li C, Jiang X et al. Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cells. Exp Hematol 2004;32:657-664.
48. Yu M, Xiao Z, Shen L et al. Mid-trimester fetal blood-derived adherent cells share characteristics similar to mesenchymal stem cells but full-term umbilical cord blood does not. Br J Haematol 2004;124:666-675.
49. Fukuchi Y, Nakajima H, Sugiyama D et al. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. STEM CELLS 2004;22:649-658.
50. In 't Anker PS, Scherjon SA, Kleijburg-van der KC et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. STEM CELLS 2004;22:1338-1345.
51. Yen BL, Huang HI, Chien CC et al. Isolation of multipotent cells from human term placenta. STEM CELLS 2005;23:3-9.
52. Hamza NS, Lisgaris M, Yadavalli G et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol 2004;124:488-498.
53. Storms RW, Goodell MA, Fisher A et al. Hoechst dye efflux reveals a novel CD7(+)CD34(-) lymphoid progenitor in human umbilical cord blood. Blood 2000;96:2125-2133.
54. Preffer FI, Dombkowski D, Sykes M et al. Lineage-negative side-population (SP) cells with restricted hematopoietic capacity circulate in normal human adult blood: Immunophenotypic and functional characterization. STEM CELLS 2002;20:417-427.
55. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
56. Rizzieri DA, Bass AJ, Rosner GL et al. Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia. J Clin Oncol 2002;20:674-679.
57. Kadereit S, Kozik MM, Junge GR et al. Cyclosporin A effects during primary and secondary activation of human umbilical cord blood T lymphocytes. Exp Hematol 2001;29:903-909.
58. van der Walt JM, Noureddine MA, Kittappa R et al. Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease. Am J Hum Genet 2004;74:1121-1127.
59. Larsson LC, Frielingsdorf H, Mirza B et al. Porcine neural xenografts in rats and mice: Donor tissue development and characteristics of rejection. Exp Neurol 2001;172:100-114.
60. Bjorklund A, Rosenblad C, Winkler C et al. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease. Neurobiol Dis 1997;4:186-200.
61. Kirik D, Rosenblad C, Bjorklund A. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor. Eur J Neurosci 2000;12:3871-3882.
62. Yoshimoto Y, Lin Q, Collier TJ et al. Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease. Brain Res 1995;691:25-36.
63. Fawcett JW, Barker RA, Dunnett SB. Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon. Exp Brain Res 1995;106:275-282.